Scrambled eggs with a side of molecular biology

(WORTHINGTON, Minn.) – Dr. Priya Anbalagan added molecular biology to the menu during the Academy of Veterinary Consultants 2017
Spring Conference in Irving, Texas, March 30 through April 1. Anbalagan, senior scientist and manager of Diagnostic Services and Technology Development, Newport Laboratories, Inc., presented her research on state-of-the-art diagnostics and bovine respiratory disease to more than 130 veterinarians at a breakfast sponsored by Merial, now part of Boehringer Ingelheim.

Anbalagan demonstrated how Newport is using cutting edge molecular technology to evaluate genetic variations of pathogens.

“By using molecular technology, we can look at genetic variations associated with virulence factors of bovine pathogens, including Histophilus Somni and Mycoplasma bovis,” says Anbalagan. “We also are looking at genetic markers and their role in bacterial antimicrobial resistance. If we have a better understanding of how the genetic deterimants relate to resistance, then we can learn more about how to control the pathogens.”

Specializing in infectious diseases, Anbalagan earned her doctorate from the Sanford School of Medicine, University of South Dakota, after completing studies in genetics and biochemistry at University of Madras, Chennai, Tamil Nadu, India. In her position at Newport Laboratories, Anbalagan created a virulence-based multi locus sequence typing of Mycoplasma bovis, supervised diagnostic test development and troubleshooting, and developed serotyping assays for Streptococcus suisPasteurella multocida, and Mannheimia hemolytica.

Molecular biology plays an integral role in modern diagnostics and animal health,” says Anbalagan. “Gene sequencing research is very intriguing and provides valuable information for diagnosing, treating and preventing BRD for veterinarians in the beef industry.”  

Anbalagan’s presentation and additional proceedings from the AVC Conference are available via the AVC website at www.AVC-beef.org or by contacting Newport Laboratories, Inc.